Do not inj IV. Not to be used for the treatment of diphtheria, tetanus, pertussis, hepatitis-B or Haemophilus influenzae
type b infection. Temp ≥40°C w/in 48 hr not due to another identifiable cause, collapse or shock-like state (hypotonic-hyporesponsive episode) w/in 48 hr, persistent crying lasting ≥3 hr occurring w/in 48 hr, convulsions w/ or w/o fever occurring w/in 3 days. High incidence of pertussis. History of febrile convulsions, family history of convulsions, sudden infant death syndrome. Immunosuppressed patients. Thrombocytopenia. Monitor patient for at least 30 min after administration. Postpone vaccination in patients w/ acute severe febrile illness.